Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing

Abstract

Circadian disruption accelerates cancer progression, whereas circadian reinforcement could halt it. Mice with P03 pancreatic adenocarcinoma (n = 77) were synchronized and fed ad libitum (AL) or with meal timing (MT) from Zeitgeber time (ZT) 2 to ZT6 with normal or fat diet. Tumor gene expression profiling was determined with DNA microarrays at endogenous circadian time (CT) 4 and CT16. Circadian mRNA expression patterns were determined for clock genes Rev-erbα, Per2, and Bmal1, cellular stress genes Hspa8 and Cirbp, and cyclin A2 gene Ccna2 in liver and tumor. The 24-hour patterns in telemetered rest-activity and body temperature and plasma corticosterone and insulin-like growth factor-I (IGF-I) were assessed. We showed that MT inhibited cancer growth by ∼40% as compared with AL (P = 0.011) irrespective of calorie intake. Clock gene transcription remained arrhythmic in tumors irrespective of feeding schedule or diet. Yet, MT upregulated or downregulated the expression of 423 tumor genes, according to CT. Moreover, 36 genes involved in cellular stress, cell cycle, and metabolism were upregulated at one CT and downregulated 12 h apart. MT induced >10-fold circadian expression of Hspa8, Cirbp, and Ccna2 in tumors. Corticosterone or IGF-I patterns played no role in tumor growth inhibition. In contrast, MT consistently doubled the circadian amplitude of body temperature. Peak and trough respectively corresponded to peak expressions of Hspa8 and Cirbp in tumors. The reinforcement of the host circadian timing system with MT induced 24-hour rhythmic expression of critical genes in clock-deficient tumors, which translated into cancer growth inhibition. Targeting circadian clocks represents a novel potential challenge for cancer therapeutics. Cancer Res; 70(8); 3351-60. ©2010 AACR.

Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival

“…Thus cancer progression was accelerated two-to three-fold in tumorbearing mice whose rest-activity rhythm was suppressed as a result of SCN ablation or chronic 'jet lag' (Fu et al, 2002;Filipski et al, 2002). Conversely CTS amplification through programmed daily meal timing halved experimental cancer growth in mice (Wu et al, 2004, Li et al, 2010. Here we investigated the clinical relevance of such preclinical findings in a large sample of cancer patients, using non invasive technology.…”

The tumor circadian clock: a new target for cancer therapy?

“…Daytime rather than nighttime administration of seliciclib, a cyclin-dependent kinase inhibitor, reduced Glasgow osteosarcoma progression, and concurrently improved the amplitude of clock gene expression rhythms within the tumor tissue [20]. Similarly, timed feeding, a major synchronizer of peripheral clocks, stimulated clock gene rhythmic expression in pancreatic adenocarcinoma, while reducing its growth speed [21]. Although these interesting animal studies were consistent with the idea that tumor-intrinsic circadian rhythms may impact on tumor growth, direct evidence was not provided.…”

ABC transporters: circadian rhythms and sex-related differences

“…Kemirgenlerde SCN'nin ameliyatla çıkarılmasıyla periferal dokularda sirkadiyan gen salınımı-nın (osilasyon) ortadan kalkması, çevresel saatlerin SCN tarafından kontrol edildiğini göstermektedir. Bununla birlikte, belirli koşullarda, örneğin dinlenme fazında besin alı-mı kısıtlandığında, çevresel saatler tamamıyla merkezi saatten ayrılabilir ve faz işaretlerini SCN'den çok beslenme zamanından alabilir (82,83,84). BMAL1, CLOCK ve NPAS2 (CLOCK'un yakından ilişkili bir paraloğu).…”